viewTHC Global Group Ltd

The Hydroponics Company brings immediate cash flow to Spotlight CEO Sessions

Find out more from Andrew Beehag at Proactive's CEO Sessions.

THC is a distributor of hydroponics equipment

The Hydroponics Company (ASX:THC) made a barnstorming debut on the ASX last week, with the shares trading at close to double the IPO entry point of $0.20 per share.

The IPO raised $8 million, and was three times oversubscribed.

THC will generate immediate cash flow through its equipment division - a proven, long-term, profitable business with over 600 products and strong distribution networks in the U.S, Canada, U.K. and Europe.

Funds will be used to expand THC’s market share as a key manufacturer and distributor of hydroponics equipment, materials and related services.

Find out more from Andrew Beehag at Proactive's CEO Sessions.

Click below to register by email

- Melbourne: Tuesday 16th May.
- Sydney: Wednesday 17th May.
- Email Pauline here.
- Call office on (02) 9280 0700.

Presenter list

- Paradigm Biopharmaceuticals (ASX:PAR): CEO Paul Rennie
- Stonewall Resources (ASX:SWJ): MD Robert Thomson
- White Rock Minerals (ASX:WRM): MD Matthew Gill
- The Hydroponics Company (ASX:THC): CEO (medicinal Cannabis division, Canndeo) Andrew Beehag

More companies to be added to the roster...

Quick facts: THC Global Group Ltd

Price: 0.265 AUD

Market: ASX
Market Cap: $46.63 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...


Full interview: THC Global Group granted GMP Licence for Southport cannabis...

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris updates Proactive on being granted a licence to manufacture therapeutic goods for the company’s Southport Facility, known as a GMP Licence, by the Australian Therapeutic Goods Administration (TGA). This milestone...

on 29/1/20

2 min read